Your browser doesn't support javascript.
loading
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk.
Almekinders, Mathilde M; Bismeijer, Tycho; Kumar, Tapsi; Yang, Fei; Thijssen, Bram; van der Linden, Rianne; van Rooijen, Charlotte; Vonk, Shiva; Sun, Baohua; Parra Cuentas, Edwin R; Wistuba, Ignacio I; Krishnamurthy, Savitri; Visser, Lindy L; Seignette, Iris M; Hofland, Ingrid; Sanders, Joyce; Broeks, Annegien; Love, Jason K; Menegaz, Brian; Wessels, Lodewyk; Thompson, Alastair M; de Visser, Karin E; Hooijberg, Erik; Lips, Esther; Futreal, Andrew; Wesseling, Jelle.
Afiliación
  • Almekinders MM; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bismeijer T; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Kumar T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Yang F; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Thijssen B; Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • van der Linden R; Department of Genetics, MD Anderson Cancer Center, Houston, TX, USA.
  • van Rooijen C; MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX, USA.
  • Vonk S; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA.
  • Sun B; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Parra Cuentas ER; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Wistuba II; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Krishnamurthy S; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Visser LL; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Seignette IM; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA.
  • Hofland I; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA.
  • Sanders J; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA.
  • Broeks A; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA.
  • Love JK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Menegaz B; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Wessels L; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Thompson AM; Department of Pathology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • de Visser KE; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Hooijberg E; Breast Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Lips E; Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
  • Futreal A; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wesseling J; Oncode Institute, Utrecht, The Netherlands.
Br J Cancer ; 127(7): 1201-1213, 2022 10.
Article en En | MEDLINE | ID: mdl-35768550
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Ductal de Mama / Carcinoma Intraductal no Infiltrante Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma Ductal de Mama / Carcinoma Intraductal no Infiltrante Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article